디하이드로아비어트산 또는 코문산을 유효성분으로 함유하는 고혈압 예방 또는 치료용 약학 조성물 및 건강식품 조성물
    4.
    发明授权
    디하이드로아비어트산 또는 코문산을 유효성분으로 함유하는 고혈압 예방 또는 치료용 약학 조성물 및 건강식품 조성물 有权
    用于预防或治疗包含脱氢胆酸或通用酸作为有效成分的高血压的PHAMACEUTICAL AND HEALTH FOOD COMPOSION

    公开(公告)号:KR101424032B1

    公开(公告)日:2014-08-01

    申请号:KR1020130040162

    申请日:2013-04-12

    CPC classification number: A23L33/105 A23V2002/00 A23V2200/3262 A61K31/192

    Abstract: According to the present invention, fractions derived from pine leaves with an inhibitory activity on an angiotensin converting enzyme are selected, and dehydroabietic acid and communic acid are identified by identifying structures among the selected materials with optimum activity. Provided are a health promotion food composition comprising dehydroabietic acid or communic acid as active ingredients for preventing or curing hypertension, a pharmaceutical composition for preventing or curing hypertension, an angiotensin converting enzyme inhibitor, and a pharmaceutical composition for preventing or curing vascular diseases. According to the present invention, dehydroabietic acid or communic acid derived from pine leaves has angiotensin converting enzyme inhibitory activity, and can be provided as a useful composition for consumer`s health. Since a method for extracting and segmenting is provided specifically in the present invention, the materials with excellent activity which is abundantly contained in pine leaves can be used as an economical raw material with a high function.

    Abstract translation: 根据本发明,选择从对血管紧张素转换酶具有抑制活性的松叶衍生的馏分,通过鉴定所选材料中具有最佳活性的结构来鉴定脱氢松香酸和通酸。 提供了包含脱氢枞酸或通讯酸作为预防或治疗高血压的有效成分的健康促进食品组合物,用于预防或治疗高血压的药物组合物,血管紧张素转换酶抑制剂和用于预防或治疗血管疾病的药物组合物。 根据本发明,脱氢枞酸或衍生自松叶的通讯酸具有血管紧张素转化酶抑制活性,可作为消费者健康的有用组合物提供。 由于在本发明中具体提供了提取和分割方法,所以可以将作为具有高功能性的经济原料用作松果中大量含有的具有优异活性的材料。

    Ry 유전자로 형질전환된 PVY에 내성이 있는 감자 식물체 및 이의 제조 방법
    6.
    发明公开
    Ry 유전자로 형질전환된 PVY에 내성이 있는 감자 식물체 및 이의 제조 방법 有权
    POTATO植物抗性与RY基因转化的PVY及其生产方法

    公开(公告)号:KR1020110002122A

    公开(公告)日:2011-01-07

    申请号:KR1020090059546

    申请日:2009-07-01

    Abstract: PURPOSE: A potato plant with resistance to PVY(potato virus Y) which is transformed by Ry gene is provided to enhance virus resistance and to overcome potato shortage due to viral diseases. CONSTITUTION: A potato plant with PVY resistance is prepared by transforming with a recombinant expression vector containing Golden Valley potato-derived Ry gene. The Ry gene has a base sequence of sequence number 1. The plant is Winter valley species. The PVY resistance of the potato is enhanced by transforming a potato plant with the recombinant expression vector.

    Abstract translation: 目的:提供具有抗Ry基因转录的PVY(马铃薯病毒Y)的马铃薯植株,以提高病毒抗性,克服由于病毒性疾病导致的马铃薯短缺。 构成:通过用含有金谷马铃薯衍生的Ry基因的重组表达载体转化制备具有PVY抗性的马铃薯植物。 Ry基因具有序列1的碱基序列。该植物是冬季谷物种。 通过用重组表达载体转化马铃薯植物来增强马铃薯的PVY抗性。

    솔잎착즙분말을 유효성분으로 포함하는 고콜레스테롤혈증의 예방 또는 개선용 조성물
    7.
    发明公开
    솔잎착즙분말을 유효성분으로 포함하는 고콜레스테롤혈증의 예방 또는 개선용 조성물 审中-实审
    用于预防或改善高脂血症的组合物,其包含松针果汁粉末作为有效成分

    公开(公告)号:KR1020160116989A

    公开(公告)日:2016-10-10

    申请号:KR1020150045511

    申请日:2015-03-31

    Abstract: 본발명은솔잎착즙분말을유효성분으로포함하는고콜레스테롤혈증의예방, 개선또는치료용조성물에관한것이다. 보다상세하게는솔잎의수분을탈수한후, 열수또는아임계추출등의추출법으로추출하지않고, 녹즙기를이용하여착즙하여얻은생즙을동결건조하여분말화한솔잎착즙분말을유효성분으로포함하는고콜레스테롤혈증의예방, 개선또는치료용조성물에관한것이다. 본발명의솔잎착즙분말은고혈압전단계대상자의혈중총콜레스테롤(TC) 및저밀도지질단백질콜레스테롤(LDL-C)을감소시키고, 고밀도지질단백질콜레스테롤(HDL-C)을증가시키는효과가있는것이다.

    발효현미 슬러리를 유효성분으로 포함하는 기능성 음료 및 이의 제조방법
    8.
    发明授权
    발효현미 슬러리를 유효성분으로 포함하는 기능성 음료 및 이의 제조방법 有权
    包含发酵糙米浆作为有效成分的功能饮料及其制备方法

    公开(公告)号:KR101649895B1

    公开(公告)日:2016-08-22

    申请号:KR1020140194736

    申请日:2014-12-31

    Abstract: 본발명은발효현미슬러리를유효성분으로포함하는기능성음료및 이의제조방법에관한것이다. 상세하게는현미와누룩을이용하여 3단계발효과정을수행하고, 상기단계에서생성된침전물을물로희석하여채로거른현미발효액을농축하는방법으로제조하는발효현미슬러리의제조방법에관한것이다. 본발명의제조방법에의해제조된발효현미슬러리는소화불량의원인인장내유해균에대한항균활성뿐만아니라항산화활성이우수하다. 따라서장 활성에도움을줄 수있는건강기능성음료또는식품으로제공하는것이가능하다.

    항혈전 활성을 갖는 폴리아크릴산 고분자 및 이의 용도
    9.
    发明授权
    항혈전 활성을 갖는 폴리아크릴산 고분자 및 이의 용도 有权
    具有抗血栓活性的聚(丙烯酸)大分子及其用途

    公开(公告)号:KR101427384B1

    公开(公告)日:2014-08-07

    申请号:KR1020130026278

    申请日:2013-03-12

    CPC classification number: A23L33/10 A23V2002/00 A23V2200/326 A61K31/185

    Abstract: The present invention relates to a polyacrylic acid macromolecule having antithrombotic activity and to uses thereof. According to the present invention, when the polyacrylic acid macromolecules is used as an antithrombotic, blood clots in blood are degraded and removed. Consequently, factors for regenerating blood clots can be basically removed. Moreover, when blood is treated with the polyacrylic acid to be stored, substances, which coagulate blood, are removed at the starting point. Therefore, the polyacrylic acid macromolecule having antithrombotic activity can prevent blood coagulation and be used for developing artificial blood powder.

    Abstract translation: 本发明涉及具有抗血栓形成活性的聚丙烯酸高分子及其应用。 根据本发明,当使用聚丙烯酸大分子作为抗血栓形成时,血液中的血块被降解和除去。 因此,可以基本上除去血块再生的因素。 此外,当用待储存的聚丙烯酸处理血液时,凝结血液的物质在起始点被去除。 因此,具有抗血栓活性的聚丙烯酸高分子可以防止血液凝结,并用于开发人造血粉。

    항혈전 활성을 갖는 프로토카테큐산 유도체 및 이의 용도
    10.
    发明授权
    항혈전 활성을 갖는 프로토카테큐산 유도체 및 이의 용도 有权
    具有抗真菌活性的丙酸酸衍生物及其用途

    公开(公告)号:KR101427381B1

    公开(公告)日:2014-08-07

    申请号:KR1020130026277

    申请日:2013-03-12

    CPC classification number: A23L33/10 A23V2002/00 A23V2200/30 A61K31/19

    Abstract: The present invention relates to a protocatechuic acid derivative having an antithrombotic activity and to a use thereof. An antithrombotic pharmaceutical composition according to the present invention can be applied to common beverages, dietary supplements, or medicine, thus is expected to be able to prevent and treat diseases involving thrombopoiesis such as arteriosclerosis, cerebral hemorrhage, stroke, or cerebral infarction.

    Abstract translation: 本发明涉及具有抗血栓形成活性的原儿茶酸衍生物及其应用。 根据本发明的抗血栓药物组合物可以应用于普通饮料,膳食补充剂或药物,因此预期能够预防和治疗涉及血小板生成(例如动脉硬化,脑出血,中风或脑梗塞)的疾病。

Patent Agency Ranking